Spots Global Cancer Trial Database for tsc seizures
Every month we try and update this database with for tsc seizures cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures | NCT01713946 | Tuberous Sclero... | RAD001 Placebo Antiepileptic d... open label RAD0... | 2 Years - 65 Years | Novartis | |
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures | NCT01713946 | Tuberous Sclero... | RAD001 Placebo Antiepileptic d... open label RAD0... | 2 Years - 65 Years | Novartis | |
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures | NCT01713946 | Tuberous Sclero... | RAD001 Placebo Antiepileptic d... open label RAD0... | 2 Years - 65 Years | Novartis |